Metformin may partially act on the AMPK/PGC-1α pathway to increase mitochondrial DNA content, improve mitochondrial morphology, and enhance mitochondrial biosynthesis to reduce peritoneal dialysis related peritoneal fibrosis in mice (91). This evidence concerns the gene PPARGC1A and Peritoneal Fibrosis.